Page 102 - Williams Hematology ( PDFDrive )

78 Part II: The Organization of the Lymphohematopoietic Tissues Chapter 5: Structure of the Marrow and the Hematopoietic Microenvironment 79

161. Taichman RS, Emerson SG: The role of osteoblasts in the hematopoietic microenviron- 195. Sapoznikov A, Pewzner-Jung Y, Kalchenko V, et al: Perivascular clusters of dendritic
ment. Stem Cells 16:7, 1998. cells provide critical survival signals to B cells in bone marrow niches. Nat Immunol
162. Ahmed N, Khokher MA, Hassan HT: Cytokine-induced expansion of human CD34+ 9:388, 2008.
stem/progenitor and CD34+CD41+ early megakaryocytic marrow cells cultured on 196. Ye M, Graf T: Early decisions in lymphoid development. Curr Opin Immunol 19:123,
normal osteoblasts. Stem Cells 17:92, 1999. 2007.
163. Robey PG, Young MF, Flanders KC, et al: Osteoblasts synthesize and respond to trans- 197. Ichii M, Shimazu T, Welner RS, et al: Functional diversity of stem and progenitor cells
forming growth factor-type beta (TGF-beta) in vitro. J Cell Biol 105:457, 1987. with B-lymphopoietic potential. Immunol Rev 237:10, 2010.
164. Haylock DN, Nilsson SK: Osteopontin: A bridge between bone and blood. Br J Haema- 198. Panaroni C, Wu JY: Interactions between B lymphocytes and the osteoblast lineage in
tol 134:467, 2006. bone marrow. Calcif Tissue Int 93:261, 2013.
165. Frisch BJ, Porter RL, Calvi LM: Hematopoietic niche and bone meet. Curr Opin Support 199. Tokoyoda K, Egawa T, Sugiyama T, et al: Cellular niches controlling B lymphocyte
Palliat Care 2:211, 2008. behavior within bone marrow during development. I Immunity. 20:707, 2004.
166. Civitelli R, Beyer EC, Warlow PM, et al: Connexin43 mediates direct intercellular com- 200. Di Rosa F, Pabst R: The bone marrow: A nest for migratory memory T cells. Trends
munication in human osteoblastic cell networks. J Clin Invest 91:1888, 1993. Immunol 26:360, 2005.
167. Dorshkind K, Green L, Godwin A, Fletcher WH: Connexin-43-type gap junctions 201. Tsuji JM, Pollack SB: Maturation of murine natural killer precursor cells in the absence of
mediate communication between bone marrow stromal cells. Blood 82:38, 1993. exogenous cytokines requires contact with bone marrow stroma. Nat Immunol 14:44, 1995.
168. Montecino-Rodriguez E, Leathers H, Dorshkind K: Expression of connexin 43(Gx43) 202. Yu H, Fehniger TA, Fuchshuber P, et al: Flt3 ligand promotes the generation of a distinct
is critical for normal hematopoiesis. Blood 96:917, 2000. CD34(+) human natural killer cell progenitor that responds to interleukin-15. Blood
169. Visnjic D, Kalajzic Z, Rowe DW, et al: Hematopoiesis is severely altered in mice with an 92:3647, 1998.
induced osteoblast deficiency. Blood 103:3258, 2004. 203. Burkett PR, Koka R, Chien M, et al: Coordinate expression and trans presentation of
170. Nakashima T, Hayashi M, Fukunaga T, et al: Evidence for osteocyte regulation of bone interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T
homeostasis through RANKL expression. Nat Med 17:1231, 2011. cell homeostasis. J Exp Med 200:825, 2004.
171. van Bezooijen RL, Roelen BA, Visser A, et al: Sclerostin is an osteocyte-expressed nega- 204. Fairfax KA, Kallies A, Nutt SL, Tarlinton DM: Plasma cell development: From B-cell
tive regulator of bone formation, but not a classical BMP antagonist. J Exp Med 199:805, subsets to long-term survival niches. Semin Immunol 20:49, 2008.
2004. 205. Varol C, Yona S, Jung S: Origins and tissue-context-dependent fates of blood mono-
172. Fulzele K, Krause DS, Panaroni C, et al: Myelopoiesis is regulated by osteocytes through cytes. Immunol Cell Biol 87:30, 2009.
Gsalpha-dependent signaling. Blood 121:930, 2013. 206. Pettit AR, Chang MK, Hume DA, Raggatt LJ: Osteal macrophages: A new twist on cou-
173. Matayoshi A, Brown C, DiPersio JF, et al: Human blood-mobilized hematopoietic pre- pling during bone dynamics. Bone 43:976, 2008.
cursors differentiate into osteoclasts in the absence of stromal cells. Proc Natl Acad Sci 207. Baldus SE, Wickenhauser C, Stefanovic A, et al: Enrichment of human bone marrow
U S A 93:10785, 1996. mononuclear phagocytes and characterization of macrophage subpopulations by
174. Edwards CM, Mundy GR: Eph receptors and ephrin signaling pathways: A role in bone immunoenzymatic double staining. Histochem J 30:285, 1998.
homeostasis. Int J Med Sci 5:263, 2008. 208. Wijffels JF, de Rover Z, Kraal G, Beelen RH: Macrophage phenotype regulation by
175. Askmyr MK, Fasth A, Richter J: Towards a better understanding and new therapeutics colony-stimulating factors at bone marrow level. J Leukoc Biol 53:249, 1993.
of osteopetrosis. Br J Haematol 140:597, 2008. 209. Shima M, Teitelbaum SL, Holers VM, et al: Et al: Macrophage-colony-stimulating fac-
176. Calle Y, Jones GE, Jagger C, et al: WASp deficiency in mice results in failure to form tor regulates expression of the integrins alpha 4, beta 1 and alpha 5, beta 1 by murine
osteoclast sealing zones and defects in bone resorption. Blood 103:3552, 2004. marrow macrophages. Proc Natl Acad Sci U S A 92:5179, 1995.
177. Horowitz MC, Lorenzo JA: The origins of osteoclasts. Curr Opin Rheumatol 16:464, 210. Dannaeus K, Johannisson A, Nilsson K, Jönsson JI: Flt3 ligand induces the outgrowth
2004. of Mac-1+B220+ mouse bone marrow progenitor cells restricted to macrophage differ-
178. Dai X-M, Zong X-H, Sylvestre V, Stanley ER: Incomplete restoration of colony- entiation that coexpress early B cell-associated genes. Exp Hematol 27:1646, 1999.
stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by trans- 211. Wright EG, Pragnell IB: Stem cell proliferation inhibitors. Baillieres Clin Haematol
genic expression of cell surface CSF-1. Blood 103:1114, 2004. 5:723, 1992.
179. Asagiri M, Takayanagi H: The molecular understanding of osteoclast differentiation. 212. Su S, Mukaida N, Wang J, et al: Inhibition of immature erythroid progenitor cell prolif-
Bone. 40:251, 2007. eration by macrophage inflammatory protein-1alpha by interacting mainly with a C-C
180. Udagawa N, Takahashi N, Yasuda H, et al: Osteoprotegerin produced by osteoblasts chemokine receptor, CCR1. Blood 90:605, 1997.
is an important regulator in osteoclast development and function. Endocrinology 213. Jacobsen SE, Ruscetti FW, Dubois CM, Keller JR: Tumor necrosis factor alpha directly
141:3478, 2000. and indirectly regulates hematopoietic progenitor cell proliferation: Role of colony-
181. Domon T, Yamazaki Y, Fukui A, et al: Ultrastructural study of cell-cell interaction stimulating factor receptor modulation. J Exp Med 175:1759, 1992.
between osteoclasts and osteoblasts/stroma cells in vitro. Ann Anat 184:221, 2002. 214. Yan XQ, Brady G, Iscove NN: Platelet-derived growth factor (PDGF) activates primitive
182. Takahashi N, Udagawa N, Suda T: A new member of tumor necrosis factor ligand fam- hematopoietic precursors (pre-CFCmulti) by up-regulating IL-1 in PDGF receptor-
ily, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. expressing macrophages. J Immunol 150:2440, 1993.
Biochem Biophys Res Commun 256:449, 1999. 215. Lerat H, Lissitzky JC, Singer JW, et al: Role of stromal cells and macrophages in
183. Shalhoub V, Faust J, Boyle WJ, et al: Osteoprotegerin and osteoprotegerin ligand effects fibronectin biosynthesis and matrix assembly in human long-term marrow cultures.
on osteoclast formation from human peripheral blood mononuclear cell precursors. J Blood 82:1480, 1993.
Cell Biochem 72:251, 1999. 216. Chow A, Lucas D, Hidalgo A, et al: Bone marrow CD169+ macrophages promote the
184. Zhao C, Irie N, Takada Y, et al: Bidirectional ephrinB2-EphB4 signaling controls bone retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell
homeostasis. Cell Metab 4:111, 2006. niche. J Exp Med 208:261, 2011.
185. Jimi E, Nakamura I, Amano H, et al: Osteoclast function is activated by osteoblastic 217. Chow A, Huggins M, Ahmed J, et al: CD169(+) macrophages provide a niche promot-
cells through a mechanism involving cell-to-cell contact. Endocrinology 137:2187, ing erythropoiesis under homeostasis and stress. Nat Med 19:429, 2013.
1996. 218. Klein G: The extracellular matrix of the hematopoietic microenvironment. Experientia
186. Mbalaviele G, Nishimura R, Myoi A, et al: Cadherin-6 mediates the heterotypic inter- 51:914, 1995.
actions between the hemopoietic osteoclast cell lineage and stromal cells in a murine 219. Bentley SA, Tralka TS: Fibronectin-mediated attachment of hematopoietic cells to stro-
model of osteoclast differentiation. J Cell Biol 141:1467, 1998. mal elements in continuous bone marrow culture. Exp Hematol 11:129, 1983.
187. Hayashi S, Miyake K, Kincade PW: The CD9 molecule on stromal cells. Leuk Lym- 220. Campbell AD, Long MW, Wicha MS: Haemonectin, a bone marrow adhesion protein
phoma 38:265, 2000. specific for cells of granulocyte lineage. Nature 329:744, 1987.
188. Oritani K, Wu X, Medina K, et al: Antibody ligation of CD9 modifies production of 221. Lawler J: The structural and functional properties of thrombospondin. Blood 67:1197,
myeloid cells in long-term cultures. Blood 87:2252, 1996. 1986.
189. Tanio Y, Yamazaki H, Kunisada T, et al: CD9 molecule expressed on stromal cells is 222. Simmons PJ, Levesque JP, Zannettino AC: Adhesion molecules in haemopoiesis. Bailli-
involved in osteoclastogenesis. Exp Hematol 27:853, 1999. eres Clin Haematol 10:485, 1997.
190. Iwama A, Yamaguchi N, Suda T: STK/RON receptor tyrosine kinase mediates both 223. Verfaille CM: Adhesion receptors as regulators of the hematopoietic process. Blood
apoptotic and growth signals via the multifunctional docking site conserved among the 92:2609, 1998.
HGF receptor family. EMBO J 15:5866, 1996. 224. Broxmeyer HE, Kim CH: Regulation of hematopoiesis in a sea of chemokine family
191. Kurihara N, Tatsumi J, Arai F, et al: Macrophage-stimulating protein (MSP) and its members with a plethora of redundant activities. Exp Hematol 27:1113, 1999.
receptor, RON, stimulate human osteoclast activity but not proliferation: Effect of MSP 225. Coombe DR: Biological implications of glycosaminoglycan interactions with haemo-
distinct from that of hepatocyte growth factor. Exp Hematol 26:1080, 1998. poietic cytokines. Immunol Cell Biol 86:598, 2008.
192. Choi SJ, Han JH, Roodman GD: ADAM8: A novel osteoclast stimulating factor. J Bone 226. Hoogewerf AJ, Kuschert GS, Proudfoot AE, et al: Glycosaminoglycans mediate cell sur-
Miner Res 16:814, 2001. face oligomerization of chemokines. Biochemistry 36:13570, 1997.
193. Oba Y, Chung HY, Choi SJ, Roodman GD: Eosinophil chemotactic factor-L (ECF-L): A 227. Luster AD, Greenberg SM, Leder P: The IP-10 chemokine binds to a specific cell surface
novel osteoclast stimulating factor. J Bone Miner Res 18:1332, 2003. heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell prolifera-
194. Crocker PR, Morris L, Gordon S: Novel cell surface adhesion receptors involved in tion. J Exp Med 182:219, 1995.
interactions between stromal macrophages and haematopoietic cells. J Cell Sci Suppl 228. Tanaka Y, Adams DH, Hubscher S, et al: T-cell adhesion induced by proteoglycan-im-
9:185, 1988. mobilized cytokine MIP-1 beta. Nature 361:79, 1993.

Kaushansky_chapter 05_p0051-0084.indd 78 9/19/15 12:11 AM